1. A dose-confirmation study to evaluate the safety, reactogenicity and immu- nogenicity of vaccine CVnCoV in healthy adults for COVID-19. https:// clinicaltrials.gov/ct2/show/NCT04515147. Accessed March 20, 2021.
2. A phase 1/2/3, placebo-controlled, randomized, observer-blind, dose-finding study to evaluate the safety, tolerability, immunogenicity, and efficacy of SARS- CoV-2 RNA vaccine candidates against COVID-19 in healthy individuals. pfe- pfizer.com. https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2020-11/C4591 001_Clinical_Protocol_Nov2020.pdf. Accessed March 20, 2021.
3. A study to evaluate efficacy, safety, and immunogenicity of mRNA-1273 vac- cine in adults aged 18 Years and older to prevent COVID-19. https://clini caltrials.gov/ct2/show/NCT04470427. Accessed March 20, 2021.
4. Artificial intelligence and COVID-19: A multidisciplinary approach;Ahuja;Integr. Med. Res.,2020
5. Deep Learning of a Pre-trained Language Model's Joke Classifier Using GPT-2;Akbar;J. Hunan Univ. Natural Sci.,2021